Clinician-Patient Communication in Lung Cancer Care
The purpose of this study is to better understand communication between patients with lung cancer and their clinicians. The investigators are also interested in patient's perceptions of the quality of communication with his/her clinician and how these perceptions may impact patient outcomes. The clinician participating in this study and has given us permission to approach his/her eligible patients for study participation.
Checked against the public recordLast updated Feb 5, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Interventions being studied
- Behavioral: Questionnaire; Behavioral: Patient Interview; Behavioral: Audio recordings of clinical consultations; Behavioral: Questionnaire; Behavioral: 2-hour empathic communication skills training; Behavioral: Standardized Patient Assessments; Behavioral: Training evaluation; Behavioral: Patient recruitment
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Patients with confirmed lung cancer diagnosis or mass suspicious of lung cancer as per clinician report and/or EMR * Lung cancer diagnosis or suspicious mass as per clinician report/EMR within 0-6 months of consent or within no more than three visits to participating clinician * Participating clinician approves his/her patient's participation in this study per clinician report. * Former (at least 100 cigarettes in lifetime and quit more than 30 days prior to enrollment) or current smoker (lifetime smoker who reports cigarette smoking within the past 30 days) as per self report or EMR; * English fluency (determined through EMR or clinician report), as we do not have the resources to translate the consultations from other languages or the surveys to other languages; * Patients must be 18 years old or older Clinician Inclusion Criteria: * An MSK attending physician (radiologists, medical oncologists, and surgeons), Nurse Practitioner (NP), Physician Assistant (PA), Fellow, Resident or Clinical Nurse Specialist (CNS) or Clinical Nurse (RN) who is a member of the Thoracic Disease Management Team or Pulmonary Service currently treating thoracic patients at MSK as per self report * Clinical has individual clinic consultations to discuss adult health assessment and/or smoking history with the target patient population: English-speaking, at least 18 years of age, has a suspicious lung mass or confirmed diagnosis, is a former/current smoker, has had no more than 3 visits with clinician or had diagnosis in past 6 months as per self-report. Exclusion Criteria: Clinician Exclusion Criteria * N/A
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Memorial Sloan Kettering Basking Ridge (Consent and follow-up only)Basking Ridge, New Jersey
- Memorial Sloan Kettering Monmouth (Consent and follow-up only)Middletown, New Jersey
- Memorial Sloan Kettering Bergen (Consent and follow-up only)Montvale, New Jersey
- Memorial Sloan Kettering Commack (Consent and follow-up only)Commack, New York
- Memorial Sloan Kettering Westchester (Consent and follow-up only)Harrison, New York
- Memorial Sloan Kettering Cancer CenterNew York, New York
- Memorial Sloan Kettering Nassau (Consent and Follow-Up only)Uniondale, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 5, 2026. Always confirm current availability with the study team.